Vanguard Tax Managed Fund FTSE Developed Markets ETF vs Vital Farms Inc — how do they compare? Vanguard Tax Managed Fund FTSE Developed Markets ETF trades at $70.35 (market cap $323.80B), while Vital Farms Inc trades at $9.33 (market cap $405.27M). The key difference: Vanguard Tax Managed Fund FTSE Developed Markets ETF is far larger — about 799× Vital Farms Inc's market cap, and Vanguard Tax Managed Fund FTSE Developed Markets ETF is trading nearer its 52-week high, Vital Farms Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vanguard Tax Managed Fund FTSE Developed Markets ETF for 131 Days and Vital Farms Inc for 14 Days on average.
| VEA | VITL | |
|---|---|---|
Market Cap | $323.80B | $405.27M |
Volume | 17,001,112 | 1,810,837 |
52-Week High | $73.79 | $43.68 |
52-Week Low | $58.90 | $8.28 |
Typical Hold Time | 131 Days | 14 Days |
Sector | — | Consumer Staples |
Enterprise Value | — | $492.28M |
Signals from Pluang's Aura AI — not financial advice
VEA trades at $70.35 with minimal daily movement (+0.13%). Technical indicators show a bearish trend with strong sell signals from moving averages and oscillators, though RSI suggests potential oversold conditions. The ETF maintains competitive advantages with a low 0.03% expense ratio and higher dividend yield compared to peers. Recent institutional activity shows mixed sentiment with both significant position increases and reductions among major holders.
VEA offers cost-efficient exposure to developed international markets excluding the US, but faces headwinds from global market volatility. The bearish technical setup and mixed institutional positioning suggest cautious near-term outlook, though the fund's structural advantages provide long-term appeal for diversified international exposure.
Vital Farms (VITL) trades at $9.435, up 2.11% today, amid a challenging period marked by volatile earnings and a bearish technical signal. The stock shows weak profitability with a net income margin of 0.02% in 2026, though valuation ratios like P/S of 0.55 appear attractive. Recent news highlights strategic review for a potential sale, with price targets ranging from $10 to $20. Cash flow remains negative, driven by heavy investing activities, while institutional interest persists with new acquisitions.
The outlook is mixed: analyst consensus is bullish with a $13.11 target, but near-term risks include pricing pressure in the egg market and earnings volatility. Recovery hinges on stabilizing supply costs and executing strategic options. Investors should weigh low valuation against operational challenges and industry headwinds for potential upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 4022 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VEA →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →